XML 107 R77.htm IDEA: XBRL DOCUMENT v3.22.4
Related Party - Additional Information (Details) - USD ($)
1 Months Ended 12 Months Ended
Nov. 07, 2022
Apr. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Fulgent Pharma | Ming Hsieh, the Chief Executive Officer and Chairman          
Related Party Transaction [Line Items]          
Percentage of ownership   100.00%      
AHMC Healthcare Inc. | Genetic Sequencing Services          
Related Party Transaction [Line Items]          
Revenue from related parties     $ 1,500,000 $ 3,400,000 $ 3,100,000
Trade accounts receivable, net from related parties     93,000 556,000  
Fulgent Pharma LLC          
Related Party Transaction [Line Items]          
Due to related parties       679,000  
Related party costs     0 0 0
Fulgent Pharma LLC | Research Development Service          
Related Party Transaction [Line Items]          
Expenses to transport employees and supplies     0 330,000 427,000
PTJ Associates Inc          
Related Party Transaction [Line Items]          
Expenses to transport employees and supplies     235,000 142,000 343,000
Accounts payable to related parties     0 0  
ANP Technologies Inc          
Related Party Transaction [Line Items]          
Due to related parties     607,000 0  
Purchase of COVID-19 antigen rapid tests kits and licensing and development services from related party     $ 1,200,000 $ 0 $ 0
ANP Technologies, Inc., | Ming Hsieh          
Related Party Transaction [Line Items]          
Ownership percentage     20.00%    
Restricted Stock Units | Fulgent Pharma | Paul Kim          
Related Party Transaction [Line Items]          
RSU assumed 77,585        
Restricted Stock Units | Fulgent Pharma | Jian Xie          
Related Party Transaction [Line Items]          
RSU assumed 129,309        
Restricted Stock Units | Fulgent Pharma | Hanlin Gao          
Related Party Transaction [Line Items]          
RSU assumed 51,723        
Restricted Stock Units | Fulgent Pharma | Other employees          
Related Party Transaction [Line Items]          
RSU assumed 117,398        
Restricted Stock Units | Fulgent Pharma | Consultants          
Related Party Transaction [Line Items]          
RSU assumed 286,998